| Session 1. Regenerative Medicine for Hard Tissue |
|
| Regenerative medicine seeks to devise new therapies for patients with severe injuries or chronic diseases in which the body's own responses do not suffice to restore functional tissue. Prerequisite factors to accomplish new organ/tissue are (1) cells, (2) scaffolds, and (3) bioactive molecules. In this session, we will present the recent advances of the application of regenerative medicine for hard tissues |
| Chair : Moon Suk KIM, Principal Research Scientist, Korea Research Institute of Chemical Tech. |
 |
| - Regenerative Medicine for Dental Application |
| Soon Jung HWANG, Associate Professor, School of Dentistry, Seoul Nat’l Univ. |
|
   |
|
| - Novel Biomaterials for Bone Regeneration |
Mark Van DYKE, Assistant Professor,
Regenerative Medicine, Wake Forest Univ. School of Medicine |
|
|
|
| - Biomechanical Effect for Tissue Regenerations |
| Soo Hyun Kim, Senior Research, Korea Institute of Science and Tech. |
|
|
|
|
| Session 2. Regenerative Medicine for Soft Tissue |
|
| Among the three factors for the regenerative medicine as cell, scaffold and bioactive molecules, cell might be the most important factor. It can be large divided three types according to cell source as (1) embryonic stem cell, (2) adult stem cell and (3) primary cell. Embryonic/adult stem cell might be differentiate/dedifferentiate to desired primary cell by the controlling the culture condition. In this session, we will introduce the types of cell for the soft tissue applications as spinal cord regeneration, bio-artificial liver and Parkinson's diseases. |
| Chair : Dong Keun HAN, Research Scientist, Korea Institute of Science and Technology |
|
| - Bioartificial Liver System |
| Jung-Keug PARK, Professor, Dongguk Univ. |
|
|
|
| - Spinal Cord Regeneration by Regenerative Medicine |
Moon Suk KIM, Principal Research Scientist,
Korea Research Institute of Chemical Tech.
|
|
|
|
- Embryonic Stem Cell for Regenerative Medicine
: Recent Advances in Embryonic Stem Cell Research |
Dong-Wook KIM, Director/Professor,
Stem Cell Research Center / Yonsei Univ. College of Medicine |
|
|
|
|
| Session 3. Commercialization Trends of Regenerative Medicine for Global Market |
|
| Final goal of engineering with medicinal science might be the human application, that is, commercialization. For the success of commercialization, medical products must be approved by government at each country system. Notably, Korean Food and Drug Administration already approved eight products as cell therapy, whereas Japan has only one product. In this session, we will discuss the strategy of global marketing for the tissue engineered and regenerative medicine products. |
| Chair : Gilson KHANG, Professor, Chonbuk Nat'l Univ. |
|
- From Bench Side to Clinical Application and Industrialization for
Regenerative Medicine; Our Experience in Japan |
Ken-ichiro HATA, Director,
Research & Development, Japan Tissue Engineering Co., Ltd. |
|
|
|
| - Bone Tissue Regeneration |
Taek-Rim YOON, Professor,
Dept. of Orthopedic Surgery, Chonnam Nat'l Univ. Hwasun Hospital |
|
|
|
- Recent Progress of “Cell-sheet Engineering”
Clinical Researches and Our
Grand Design of “Medical Value-chain” for
Global Regenerative Medicine |
Mime EGAMI, Visiting Professor,
Institute of Advanced Biomedical & Science, Tokyo Womans Medical Univ. |
|
 |
|
|
|
